Fig 1.
PRISMA flow diagram a = number of studies excluded for device respected the same order as the main boxes.
Table 1.
Baseline characteristics of included studies.
Table 2.
IOP and antiglaucoma medication values at baseline and one year in RCT and NRS.
Table 3.
IOP and antiglaucoma medication at baseline and one year in before-after studies.
Table 4.
Pre- and post-operative intraocular pressure and glaucoma medications at last follow-up visit of included studies.
Fig 2.
Forest plot for comparison in IOP change between study arms at 12-months (divided by device and procedure).
Values expressed in Weighed Mean Difference (WMD).
Fig 3.
Forest plot for 12-months difference in change in number of glaucoma medications reduction (divided by device and procedure) values expressed in Weighed Mean Difference (WMD).
Fig 4.
Forest plot for 12-months IOP reduction (divided by device and procedure).Values expressed in Weighed Mean Difference (WMD).
Fig 5.
Forest plot for 12-months number of medication reduction (divided by device and procedure).
Values expressed in Weighed Mean Difference (WMD).
Table 5.
Surgery-related adverse events of included studies.